Stage 7: Shared Decisions & Prescribing in the Encounter
Concept 6 of 8
E7.6

Discussing Side Effects

Honest, calibrated, proactive. Patients who know what to expect tolerate side effects better and adhere better.

Encounter card
Setting
Every prescription. Address the common AEs that affect adherence (sexual, weight, sedation, GI), the serious AEs that need monitoring (suicidality, NMS, serotonin syndrome), and the patient's specific concerns.
Opening move
Frame side effects honestly without overwhelming. Discuss likelihood, severity, timeline, and what to do. Address the patient's specific concerns explicitly.
Sample language
  • "Most people experience some side effects, especially in the first few weeks. Let me tell you what to expect."
  • "The most common are X, Y, Z. They usually start within the first week and often improve over 2-4 weeks."
  • "Rare but serious — call me if you notice X."
  • "What concerns you most about side effects? Let's talk about that specifically."
Listen for
Patient's specific concerns (often differ from what the clinician anticipates). Prior negative experiences. Cultural or relational concerns about specific AEs (sexual dysfunction may be especially salient for some patients).
Common pitfalls
Glossing over side effects to encourage adherence (backfires when they emerge). Listing every possible side effect (overwhelming). Not asking about the patient's specific concerns. Failing to discuss sexual dysfunction with patients who may not bring it up.

Red flags / escalate: Patient minimizes side effects but then doesn't adhere. Patient discontinues abruptly without informing clinician.

Documentation
AEs discussed, written materials provided if appropriate, what to call about.

Real-world reality: Threats require institutional protocol activation — risk management, security, possibly police, possibly Tarasoff warning. Know the institutional process; don't freelance.

Honest, calibrated discussion of side effects builds trust and adherence. Surprise side effects damage both.

Warm grey-tinted clinical notebook page, muted teal accent. Honest side effect discussion — common, likely-temporary AEs first; rare serious ones noted. Margin clusters on the calibration.

Discussing side effects honestly is one of the highest-leverage moves in prescribing. The patient who is warned and prepared tolerates side effects better, recognizes them earlier, and engages with you when they emerge. The patient who is surprised by side effects often discontinues medication without telling you and returns weeks later with the original symptoms unchanged.

Honest without overwhelming. Listing every possible side effect from the package insert produces information overload. Focus on the common ones the patient will likely encounter, the serious ones they need to recognize, and the ones likely to limit adherence specifically. Calibrate to the patient — the anxious patient who Googles everything needs different framing than the patient who wants minimal detail.

Common AEs: what to expect, when, how long it typically lasts, what to do if it bothers them. "GI symptoms in the first 1-2 weeks are common; usually resolve by week 3. Take with food. Let me know if it's severe enough that you want to stop." Setting expectations prevents the first-week discontinuation that loses half of adherence cases.

Serious AEs: rare but important to recognize. "If you develop a rash, stop the medication and call me immediately." "If you experience confusion or muscle stiffness with fever, this is a medical emergency — go to the ED." Name specifically what would prompt urgent contact; the patient who knows what to watch for catches problems earlier.

Ask the patient's specific concerns. "What worries you most about side effects?" Often the patient's specific concern is different from what you'd anticipate. The young man worried about sexual dysfunction. The patient with prior weight issues worried about weight gain. The patient with a parent who had bad medication reactions worried about idiosyncratic responses. Address the specific concern.

Sexual side effects deserve specific discussion. SSRIs cause sexual dysfunction in 30-70 percent of patients; many won't volunteer the topic. Raise it: "These medications commonly cause sexual side effects — delayed orgasm, lower libido, sometimes erectile difficulty. I bring it up because it's common and because there are options if it happens." Normalize and pre-empt; otherwise patients silently discontinue.

Surprise side effects damage trust. The patient who experiences something you didn't warn them about wonders what else you haven't told them. Honest, calibrated discussion at prescription builds the trust that makes adherence possible.

Common AEs (manage in encounter) vs rare serious AEs (call immediately). Margin notes on the framing.
The anchor

Discuss side effects honestly, calibrated to severity and likelihood. Address common AEs proactively, ask the patient's specific concerns, name what would prompt urgent contact.

Asking the patient's specific concerns directly — often differs from what the clinician anticipated. Sample examples.
Prove it

You're starting an SSRI in a 30-year-old man with depression. He's in a relationship. What sexual side effect discussion is essential?

This connects to

Locked concepts unlock as you reach them on the path.

Back